Valeant Pharmaceuticals International (VRX) is considering the sale of an Egyptian drug maker it bought last year, Bloomberg’sManuel Baigorri and Dinesh Nair are reporting:
Valeant Pharmaceuticals International Inc. is considering the sale of Egyptian drugmaker Amoun Pharmaceutical Co. as the beleaguered Canadian company seeks to accelerate its debt-reduction plans, according to people with knowledge of the matter.
Amoun may attract pharmaceutical companies with an interest in expanding in emerging markets, the people said, asking not to be identified because the deliberations are private. The Egyptian companys current executives could also pursue a management buyout with help from financial investors, though no final decision has been made, the people said.
Valeant is working with Goldman Sachs Group Inc. on the sale, which is at a preliminary stage, the people said. Valeant agreed to acquire Amouns holding company Mercury Holdings last year for about $800 million, plus some contingent payments. Valeants intentions at the time were to use Amoun as a platform to further expand in the Middle East and Africa.
Top 10 Gold Stocks To Buy For 2018: LightInTheBox Holding Co., Ltd.(LITB)
Advisors’ Opinion:
- [By Peter Graham]
Small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) reportedQ1 2017 earnings as net revenues increased 8.0% to $72.7 million (above the high end of the Company’s guidance of $72.0 million). Net revenues from product sales were $64.8 million versus$61.9 million and net revenues from service and others were $7.9 million versus $5.4 million in the same quarter of 2016. As a percentage of net revenues, service and others accounted for 10.9% during the first quarter of 2017. Total orders of product sales were 1.6 million for the first quarter of 2017 versus1.7 million in the same quarter of 2016 while the total number of product sales customers was 1.2 million versus 1.4 million.
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggested small cap China based online retailstockLightinthebox Holding Co (NYSE: LITB) as a long/buy trade:
Top 10 Gold Stocks To Buy For 2018: Syngenta AG(SYT)
Advisors’ Opinion:
- [By WWW.THESTREET.COM]
Syngenta AG (SYT) CEO Erik Fyrwald said Wednesday that he was “entirely confident” the company’s $43 billion takeover by China National Chemical Corp. would close in the second quarter of this year and dismissed suggestions it would be disrupted by a third party.
- [By Shanthi Rexaline]
Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers
Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.
Agri-Finance Companies
Top 10 Gold Stocks To Buy For 2018: Alder BioPharmaceuticals, Inc.(ALDR)
Advisors’ Opinion:
- [By Paul Ausick]
Alder Biopharmaceuticals Inc. (NASDAQ: ALDR) posted a new 52-week low of $13.50on Tuesday, down nearly 28% compared with Monday’s closing price of $18.70. The stock’s 52-week high is $36.48. Volume totaled more than 12 million shares, about 12 times the daily average of around 720,000. The company reported that its migraine treatment reported a positive result, but investors were not impressed.
Top 10 Gold Stocks To Buy For 2018: Intec Pharma Ltd.(NTEC)
Advisors’ Opinion:
- [By Lisa Levin]
Intec Pharma Ltd (NASDAQ: NTEC) shares were also up, gaining 14 percent to $5.53. Intec Pharma priced 10.6 million share offering at $4.70 per share.
- [By Lisa Levin]
Intec Pharma Ltd (NASDAQ: NTEC) shares dropped 25 percent to $5.57. Intec Pharma reported a Q3 loss of $0.29 per share.
Shares of Diplomat Pharmacy Inc (NYSE: DPLO) were down 23 percent to $14.71. Diplomat Pharmacy agreed to buy LDI Integrated Pharmacy Services. Baird downgraded Diplomat Pharmacy from Outperform to Neutral.
Top 10 Gold Stocks To Buy For 2018: OncoSec Medical Incorporated(ONCS)
Advisors’ Opinion:
- [By Lisa Levin]
Losers
DBV Technologies SA – ADR (NASDAQ: DBVT) shares tumbled 50.6 percent to $23.73 after the company disclosed that its peanut allergy trial failed to meet primary endpoint.
Connecture Inc (NASDAQ: CNXR) shares declined 40.8 percent to $0.290. Connecture reported that it will voluntarily delist from the NASDAQ for OTCQX Market.
Walter Investment Management Corp (NYSE: WAC) slipped 19.2 percent to $0.410. On Friday, Walter Investment Management disclosed that it has reached an agreement with term lenders and senior noteholders on financial restructuring.
Eldorado Gold Corp (USA) (NYSE: EGO) shares dropped 15.9 percent to $1.83. Eldorado Gold lowered its production guidance for its Kisladag operation.
Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) shares fell 15.4 percent to $1.04.
Future Fintech Group Inc (NASDAQ: FTFT) dropped 13.6 percent to $1.53. Future FinTech reported filing of proxy statement, including proposal for corporate restructuring.
Concordia International Corp (NASDAQ: CXRX) shares fell 12.3 percent to $0.500 after dipping 38.71 percent on Friday.
Aemetis Inc (NASDAQ: AMTX) shares declined 11.3 percent to $0.550
OncoSec Medical Inc (NASDAQ: ONCS) dipped 10.5 percent to $1.12. OncoSec reported a $7.1 million registered direct at-the-market offering at a price of $1.34375 per share.
Evoke Pharma Inc (NASDAQ: EVOK) shares fell 10.35 percent to $3.08 after the company disclosed 'positive' topline results from comparative exposure pharmacokinetic study for Gimoti.
Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) shares dropped 9.4 percent to $11.60 as the company disclosed Phase 2 interim 24-week data with pegylated interferon lambda in Hepatitis Delta Virus infection at the American Association for the Study of Liver Diseases Meeting.
Viking Therapeutics Inc (NASDAQ: VKTX) shares slipped 6.6 percent to $2.80. Viking Therapeutics presented results from proof-of-concept study of VK0214 in in vivo
Top 10 Gold Stocks To Buy For 2018: GSE Systems, Inc.(GVP)
Advisors’ Opinion:
- [By Jim Robertson]
On Thursday, our Under the Radar Moversnewsletter suggestedbuying small cap performance improvement stock GSE Systems (NYSEMKT: GVP):
GSE Systems is another somewhat-preemptive position; we think the recent support at the 100-day moving average line (gray) and subsequent string of higher lows is telling. There’s a ceiling at $3.27 that needs to be cleared, but we fear waiting on that to happen because once it does, GVP shares could be catapulted to a price we don’t want to chase.
Top 10 Gold Stocks To Buy For 2018: Neptune Technologies & Bioresources Inc(NEPT)
Advisors’ Opinion:
- [By Monica Gerson]
Neptune Technologies & Bioressources (NASDAQ: NEPT) is projected to post a quarterly loss at $0.01 per share on revenue of $9.70 million.
Apigee Corp (NASDAQ: APIC) is expected to post a quarterly loss at $0.27 per share on revenue of $23.17 million.
- [By Jim Robertson]
Yesterday, our Under the Radar Movers newsletter suggested small cap functional ingredient stock Neptune Technologies & Bioressources (NASDAQ: NEPT) as a long/bullish trade:
Top 10 Gold Stocks To Buy For 2018: Isle of Capri Casinos Inc.(ISLE)
Advisors’ Opinion:
- [By Lisa Levin]
Isle of Capri Casinos (NASDAQ: ISLE) shares shot up 30 percent to $22.03. Eldorado Resorts, Inc. (NYSE: ERI) and Isle of Capri Casinos, Inc. struck a merger deal through which the former would buy the latter for $23 a share in cash or 1.638 shares.
- [By Lisa Levin]
Isle of Capri Casinos (NASDAQ: ISLE) reported better-than-expected earnings for its fourth quarter on Tuesday.
The company posted adjusted earnings of $0.62 per share on revenue of $264.9 million. However, analysts were expecting earnings of 0.54 per share on revenue of $266.8 million.
- [By Lee Jackson]
Isle of Capri Casinos Inc. (NASDAQ: ISLE) had the president of the company selling some stock. Arnold Block parted with 63,648 shares of the gaming company at $26.20 per share. The total for the sale cameto $2 million. He was joined by CEO Eric Hausler and the chief legal officer, Edmund Quatmann, who together sold 163,949 shares forbetween $26.02 and $26.26. Their trades totaled $4 million.The shares closed on Friday at $25.45, so well-timed trades indeed.The 52-week trading range is $13.01 to $26.89, and the consensus price objective is $23.
Top 10 Gold Stocks To Buy For 2018: Flagstar Bancorp, Inc.(FBC)
Advisors’ Opinion:
- [By Dustin Blitchok]
When Alessandro DiNello was named CEO of Flagstar Bancorp Inc (NYSE: FBC) in 2013, the bank was on a financial precipice.
The bank’s business was almost entirely mortgages. As the industry unraveled nationally, Flagstar accepted $267 million in TARP money in 2009 — as well as private equity financing — to maintain solvency.
Top 10 Gold Stocks To Buy For 2018: Manitex International Inc.(MNTX)
Advisors’ Opinion:
- [By Lisa Levin]
In trading on Thursday, industrial shares fell by 0.08 percent. Meanwhile, top losers in the sector included Accenture Plc (NYSE: ACN), down 4 percent, and Manitex International Inc (NASDAQ: MNTX), down 4 percent.
